A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Anileridine
Ancrod
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Ancrod.
Anileridine
Defibrotide
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Defibrotide.
Anileridine
Desmoteplase
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Desmoteplase.
Anileridine
Ximelagatran
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Ximelagatran.
Anileridine
Coumarin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Coumarin.
Anileridine
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with 4-hydroxycoumarin.
Anileridine
Epoprostenol
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Epoprostenol.
Anileridine
Enoxaparin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Enoxaparin.
Anileridine
Heparin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Heparin.
Anileridine
Phenprocoumon
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Phenprocoumon.
Anileridine
Abiraterone
The serum concentration of Antipyrine can be increased when it is combined with Abiraterone.
Anileridine
Tenofovir
Antipyrine may increase the nephrotoxic activities of Tenofovir.
Anileridine
Tenofovir alafenamide
Antipyrine may increase the nephrotoxic activities of Tenofovir alafenamide.
Anileridine
Pralatrexate
Antipyrine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Anileridine
Lithium hydroxide
Antipyrine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Anileridine
Lithium carbonate
Antipyrine may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Anileridine
Lithium citrate
Antipyrine may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
Anileridine
Hydralazine
Antipyrine may decrease the antihypertensive activities of Hydralazine.
Anileridine
Drospirenone
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Drospirenone.
Anileridine
Acetyldigoxin
Antipyrine may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3